Skip to main content
Dryad

Identification of a natural product inhibitor of SARS-CoV-2 Mpro through integrated virtual screening, DFT, and molecular dynamics simulations

Data files

Sep 09, 2026 version files 136.26 MB

Click names to download individual files

Abstract

This dataset contains computational data from a virtual screening procedure to identify SARS-CoV-2 Mpro inhibitors. Approximately 220,000 natural product compounds from ZINC15 were screened using ADMET filtering, molecular docking against Mpro (PDB ID: 6LU7), and docking against hMAT1A and CYP450 isoforms to evaluate hepatotoxicity and drug clearance. Top compounds were subjected to DFT calculations, followed by MD simulations with post-MD analyzes of the top lead molecule (Lig14) (COM trajectory extraction, sub-diffusive behavior, MM-GBSA, and alchemical solvation free-energy calculations). Mutational analysis was performed on relevant mutants (G143S, G143D, G143N, C145Y, E166K) to assess resistance profiles. The dataset contains (1) filtered ligand library details; (2) DFT-optimized structured files for the top four compounds; (3) MD trajectory files for the lead molecule (Lig14); and (4) mutational analysis (PDB files and sequences) for wild-type and mutant Mpro complexes. This resource facilitates method validation, comparative analysis, and future computational drug discovery research.